Xepi

Product manufactured by Biofrontera Inc.

Application Nr Approved Date Route Status External Links
NDA208945 None Topical None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Xepi™ Is Indicated For The Topical Treatment Of Impetigo Due To Staphylococcus Aureus Or Streptococcus Pyogenes In Adult And Pediatric Patients 2 Months Of Age And Older [See Clinical Studies (14) ] . Xepi Is A Quinolone Antimicrobial Indicated For The Topical Treatment Of Impetigo Due To Staphylococcus Aureus Or Streptococcus Pyogenes In Adult And Pediatric Patients 2 Months Of Age And Older ( 1 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Ozenoxacin

Comments